Literature DB >> 27596146

[Allogeneic stem cell transplantation : An option for autoimmune diseases?]

S Wirths1, W Bethge2, J C Henes2.   

Abstract

According to experimental animal models and experiences of patients with coexisting autoimmune diseases, allogeneic stem cell transplantation has the potential to reestablish and maintain immunological tolerance. On the other hand, it is associated with significant treatment related mortality and may induce diverse immunological diseases by graft-versus-host reaction. Other than with severe aplastic anemia, it is not an established therapy for autoimmune diseases; it is under investigation in clinical trials and might be considered in severe, refractory immune cytopenia.

Entities:  

Keywords:  Allogeneic stem cell transplantation; Chimerism; Graft-versus-host disease; Immune tolerance; Treatment-related mortality

Mesh：

Year:  2016        PMID： 27596146     DOI： 10.1007/s00393-016-0194-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


  30 in total

1.  Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.

Authors:  John A Snowden; Rachel M Pearce; Julia Lee; Keiren Kirkland; Maria Gilleece; Paul Veys; Richard E Clark; Majid Kazmi; Mario Abinun; Graham H Jackson; Stephen Mackinnon; Nigel H Russell; Gordon Cook
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

Review 2.  Allogeneic stem cell transplantation in a patient with myelodysplastic syndrome and polyarteritis nodosa: a case report and systematic review.

Authors:  Mirte Stavenga; Helen L Leavis; Theo M de Witte; Reinier A P Raymakers
Journal:  Ann Hematol       Date:  2016-01-20       Impact factor: 3.673

3.  Target populations in allogeneic hematopoietic cell transplantation for autoimmune diseases--a workshop accompanying: cellular therapy for treatment of autoimmune diseases, basic science and clinical studies, including new developments in hematopoietic and mesenchymal stem cell therapy.

Authors:  Linda M Griffith; Steven Z Pavletic; Alan Tyndall; Alois Gratwohl; Daniel E Furst; Stephen J Forman; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2006-06       Impact factor: 5.742

4.  Pure white cell aplasia (PWCA) relapsing after allogeneic BMT and successfully treated with nine DLIs.

Authors:  A M Marmont; A Dominietto; F Gualandi; G Piaggio; M T van Lint; A Bacigalupo
Journal:  Biol Blood Marrow Transplant       Date:  2006-09       Impact factor: 5.742

5.  Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

Authors:  Marcelo C Pasquini; Julio Voltarelli; Harold L Atkins; Nelson Hamerschlak; Xiaobo Zhong; Kwang Woo Ahn; Keith M Sullivan; George Carrum; Jeffrey Andrey; Christopher N Bredeson; Mitchell Cairo; Robert Peter Gale; Theresa Hahn; Jan Storek; Mary M Horowitz; Peter A McSweeney; Linda M Griffith; Paolo A Muraro; Steven Z Pavletic; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-13       Impact factor: 5.742

6.  Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis.

Authors:  L D McAllister; P G Beatty; J Rose
Journal:  Bone Marrow Transplant       Date:  1997-02       Impact factor: 5.483

7.  Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation.

Authors:  J L Nelson; R Torrez; F M Louie; O S Choe; R Storb; K M Sullivan
Journal:  J Rheumatol Suppl       Date:  1997-05

8.  Course of Crohn's disease after allogeneic marrow transplantation.

Authors:  S O Lopez-Cubero; K M Sullivan; G B McDonald
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

Review 9.  Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Authors:  A Sureda; P Bader; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; J C Marsh; A Nagler; C Peters; A Velardi; M Mohty; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

10.  Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma.

Authors:  C Tapprich; R Fenk; P Schneider; A Bernhardt; R Haas; G Kobbe
Journal:  Bone Marrow Transplant       Date:  2003-09       Impact factor: 5.483
View more
  1 in total

1.  Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide.

Authors:  A Unnikrishnan; S C Glover; O Norkina; J R Wingard; M Norkin
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.